Investor Centre
Investor Centre
Welcome to the Acrux Limited investor centre. This section is designed to give current and potential investors access to our important public information.
Annual Report 2014
2014 has been a challenging year for Acrux. However, shareholders received a dividend of 20 cents per share from two dividend payments as a result of Acrux maintaining a strong revenue stream during the financial year…
Latest Announcements
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Axiron Net Sales, quarter to March 2015 | 24/04/2015 | ||
| ACR | Change in substantial holding | 10/03/2015 | ||
| ACR | Call on the FDA Drug Safety Communication | 04/03/2015 | ||
| ACR | FDA Testosterone update | 04/03/2015 | ||
| ACR | Director Resignation | 26/02/2015 |
